Logo
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ελληνικά 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Σύνδεση
Προβολή τεκμηρίου 
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Προβολή τεκμηρίου
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Προβολή τεκμηρίου
JavaScript is disabled for your browser. Some features of this site may not work without it.
Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
Όλο το DSpace
  • Κοινότητες & Συλλογές
  • Ανά ημερομηνία δημοσίευσης
  • Συγγραφείς
  • Τίτλοι
  • Λέξεις κλειδιά

Multicenter cross-sectional study of patients with rheumatoid arthritis in Greece: Results from a cohort of 2.491 patients

Thumbnail
Συγγραφέας
Thomas K., Lazarini A., Kaltsonoudis E., Drosos A., Papalopoulos I., Sidiropoulos P., Katsimbri P., Boumpas D., Tsatsani P., Gazi S., Fragkiadaki K., Tektonidou M., Sfikakis P.P., Pantazi L., Boki K.A., Grika E.P., Vlachoyiannopoulos P.G., Karagianni K., Sakkas L.I., Dimitroulas T., Garyfallos A., Kassimos D., Evangelatos G., Iliopoulos A., Areti M., Georganas C., Melissaropoulos K., Georgiou P., Vounotrypidis P., Ntelis K., Mavragani C.P., Bournazos I., Katsifis G., Mavrommatis C., Kitas G.D., Vassilopoulos D.
Ημερομηνία
2018
Γλώσσα
en
DOI
10.31138/mjr.29.1.27
Λέξη-κλειδί
analgesic agent
disease modifying antirheumatic drug
rheumatoid factor
tumor necrosis factor inhibitor
adult
Article
chronic hepatitis B
chronic hepatitis C
clinical evaluation
clinical feature
cohort analysis
comorbidity assessment
cross-sectional study
depression
diabetes mellitus
disease activity
disease duration
female
Greece
herpes zoster
human
hyperlipidemia
hypertension
interferon gamma release assay
lung tuberculosis
major clinical study
male
middle aged
multicenter study
osteoporosis
Parainfluenza virus infection
phase 1 clinical trial
phase 2 clinical trial
phase 3 clinical trial
pneumococcal infection
prospective study
rheumatoid arthritis
tertiary care center
treatment duration
treatment outcome
tuberculin test
vaccination coverage
virus infection
Greek Rheumatology Society and Professional Association of Rheumatologists
Εμφάνιση Μεταδεδομένων
Επιτομή
Aim of the study: To evaluate the current disease characteristics, treatment and comorbidities of rheumatoid arthritis (RA) in Greece. Methods: Multicenter, cross-sectional study with a 9-month recruitment period between 2015 and 2016. Demographics, disease characteristics, treatment and comorbidities were collected via a web-based platform. Results:2.491 RA patients were recruited: 96% from tertiary referral centers, 79% were females with a mean age of 63.1 years and disease duration of 9.9 years. Fifty-two percent were rheumatoid factor and/or anti-CCP positive, while 41% had erosive disease. Regarding treatment, 82% were on conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs), 42% on biologic DMARDs (TNFi: 22%, non-TNFi: 20%) and 40% on corticosteroids (mean daily dose: 5.2 mg). Despite therapy, 36% of patients had moderate and 12% high disease activity. The most frequent comorbidities were hypertension (42%), hyperlipidemia (33%), osteoporosis (29%), diabetes mellitus (15%) and depression (12%). Latent tuberculosis infection (positive tuberculin skin test or interferon gamma release assay) was diagnosed in 13 and 15.3% of patients, respectively. Regarding chronic viral infections, 6.2% had history of herpes zoster while 2% and 0.7% had chronic hepatitis B and C virus infection, respectively. A history of serious infection was documented in 9.6%. Only 36% and 52% of the participants had ever been vaccinated against pneumococcus and influenza virus, respectively. Conclusion: This is one of the largest epidemiologic studies providing valuable data regarding the current RA characteristics in Greece. Half of patients were seropositive but despite therapy, half displayed residual disease activity, while preventive vaccination was limited. © Thomas K, Lazarini A, Kaltsonoudis E, Drosos AA, Papalopoulos I, Sidiropoulos P, Katsimbri P, Boumpas D, Tsatsani P, Gazi S, Fragkiadaki K, Tektonidou M, Sfikakis P P, Pantazi L, Boki K A, Grika E P, Vlachoyiannopoulos P G, Karagianni K, Sakkas L I, Dimitroulas T, Garyfallos A, Kassimos D, Gerasimos E, Iliopoulos A, Areti A, Georganas C, Melissaropoulos K, Georgiou P, Vounotrypidis P, Ntelis K, Mavragani C P, Bournazos I, Katsifis G, Mavrommatis C, Kitas G D, Vassilopoulos D.
URI
http://hdl.handle.net/11615/79705
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Direct oral anticoagulant-vs Vitamin K antagonist-related nontraumatic intracerebral hemorrhage 

    Tsivgoulis G., Lioutas V.-A., Varelas P., Katsanos A.H., Goyal N., Mikulik R., Barlinn K., Krogias C., Sharma V.K., Vadikolias K., Dardiotis E., Karapanayiotides T., Pappa A., Zompola C., Triantafyllou S., Kargiotis O., Ioakeimidis M., Giannopoulos S., Kerro A., Tsantes A., Mehta C., Jones M., Schroeder C., Norton C., Bonakis A., Chang J., Alexandrov A.W., Mitsias P., Alexandrov A.V. (2017)
    Objective: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular ...
  • Thumbnail

    Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 

    Agrawal R., Gunasekeran D.V., Grant R., Agarwal A., Kon O.M., Nguyen Q.D., Pavesio C., Gupta V., Gupta B., Aggarwal K., Murthy S.L., Westcott M., Phaik C.S., McCluskey P., Ling H.S., Teoh S., Cimino L., Biswas J., Narain S., Agarwal M., Mahendradas P., Khairallah M., Jones N., Tugal-Tutkun I., Babu K., Basu S., Carreño E., Lee R., Al-Dhibi H., Bodaghi B., Invernizzi A., Goldstein D.A., Herbort C.P., Barisani T., González-López J.J., Androudi S., Bansal R., Moharana B., Mahajan S., Esposti S., Tasiopoulou A., Nadarajah S., Agarwal M., Abraham S., Vala R., Singh R., Sharma A., Sharma K., Zierhut M., Raje D., Cunningham E., Kempen J., Collaborative Ocular Tuberculosis Study (COTS)-1 Study Group (2017)
    IMPORTANCE Eradication of systemic tuberculosis (TB) has been limited by neglected populations and the HIV pandemic. Whereas ocular TB often presents as uveitis without any prior evidence of systemic TB, the existing ...
  • Thumbnail

    TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting 

    Fountzilas G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., Lakis S., Bobos M., Poulios C., Sotiropoulou M., Lyberopoulou A., Gogas H., Pentheroudakis G., Pectasides D., Koutras A., Christodoulou C., Papandreou C., Samantas E., Papakostas P., Kosmidis P., Bafaloukos D., Karanikiotis C., Dimopoulos M.-A., Kotoula V. (2016)
    Background: We investigated the impact of PIK3CA and TP53 mutations and p53 protein status on the outcome of patients who had been treated with adjuvant anthracycline-taxane chemotherapy within clinical trials in the pre- ...
htmlmap 

 

Πλοήγηση

Όλο το DSpaceΚοινότητες & ΣυλλογέςΑνά ημερομηνία δημοσίευσηςΣυγγραφείςΤίτλοιΛέξεις κλειδιάΑυτή η συλλογήΑνά ημερομηνία δημοσίευσηςΣυγγραφείςΤίτλοιΛέξεις κλειδιά

Ο λογαριασμός μου

ΣύνδεσηΕγγραφή (MyDSpace)
Πληροφορίες-Επικοινωνία
ΑπόθεσηΣχετικά μεΒοήθειαΕπικοινωνήστε μαζί μας
Επιλογή ΓλώσσαςΌλο το DSpace
EnglishΕλληνικά
htmlmap